111 (YI) Total Non-Current Liabilities (2018 - 2025)
111's (YI) quarterly Total Non-Current Liabilities came in at $279.7 million in Q4 2025, down 16.22% year-on-year from $333.8 million in Q4 2024, and down 11.48% quarter-over-quarter from $316.0 million in Q3 2025.
111 (YI) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends
111 has disclosed Total Non-Current Liabilities across 8 years of filings, most recently posting $279.7 million for Q4 2025.
- Total Non-Current Liabilities for Q4 2025 came in at $279.7 million, down 16.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $279.7 million (down 16.22% YoY), and the FY2025 annual result was $276.0 million, down 15.98% from the prior year.
- Total Non-Current Liabilities came in at $279.7 million for Q4 2025 at 111, down from $316.0 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $395.9 million in Q4 2022 to a low of -$1.2 billion in Q2 2025.
- The 5-year median for Total Non-Current Liabilities is $340.5 million (2021), against an average of $205.0 million.
- Across the five-year window, Total Non-Current Liabilities surged 203.08% in 2022 and tumbled 443.87% in 2025, its largest moves.
- 111's Total Non-Current Liabilities stood at $359.0 million in 2021, then advanced by 10.28% to $395.9 million in 2022, then slipped by 1.5% to $390.0 million in 2023, then decreased by 14.39% to $333.8 million in 2024, then declined by 16.22% to $279.7 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $279.7 million (Q4 2025), $316.0 million (Q3 2025), and -$1.2 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.72 Mn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.37 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 329.13 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 6.05 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.79 Bn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 58.52 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 279.68 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 40.66 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 279.68 Mn |
| Sep 30, 2025 | 315.96 Mn |
| Jun 30, 2025 | -1.20 Bn |
| Mar 31, 2025 | 305.59 Mn |
| Dec 31, 2024 | 333.84 Mn |
| Sep 30, 2024 | 386.72 Mn |
| Jun 30, 2024 | 348.81 Mn |
| Mar 31, 2024 | 365.51 Mn |
| Dec 31, 2023 | 389.95 Mn |
| Dec 31, 2022 | 395.88 Mn |
| Sep 30, 2022 | 333.61 Mn |
| Jun 30, 2022 | 354.87 Mn |
| Dec 31, 2021 | 358.98 Mn |
| Sep 30, 2021 | -323.66 Mn |
| Jun 30, 2021 | 347.11 Mn |
| Mar 31, 2021 | 286.09 Mn |
| Dec 31, 2020 | 255.33 Mn |
| Sep 30, 2020 | 268.22 Mn |
| Jun 30, 2020 | 182.53 Mn |
| Mar 31, 2020 | 137.51 Mn |